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EVAR in the NSQIP from 2005 to 2012 were identiﬁed.
Patients with nondeath, same-calendar-day discharge after
EVAR had aEVAR, whereas others had iEVAR. Demo-
graphics and outcomes were compared. Charges for
aEVAR and iEVAR (1 to 2 day stay only) were compared
using the Florida Inpatient and Ambulatory Surgery Data-
bases from 2006 to 2009.
Results: A total of 16,420 patients received EVAR: 53
aEVAR and 16,367 iEVAR. The aEVAR patients were
younger (69 vs 74 years; P ¼ .003), more often female
(32% vs 18%; P ¼ .011), and less likely to have creatinine
>1.2g/dL (14% vs 28%; P ¼ .027). Femoral cutdown
rate did not differ between aEVAR and iEVAR (45% vs
50%; P ¼ .495). Predischarge complications after aEVAR
included DVT (one), return to the operating room
(two), and transfusion (two). Postdischarge complications
included transfusion (two) and deep venous thrombosis
(one). Administrative data showed median total charges
of $59,100 for aEVAR (n ¼ 36) compared with $81,724
for iEVAR (n ¼ 5,725).
Conclusions: Although aEVAR sample size is limited,
this multicenter, national database shows aEVAR has
acceptable morbidity in select patients. Further studies
may delineate aEVAR candidate selection criteria and
explore differential resource utilization between aEVAR
and iEVAR.
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Shaﬁi, Timur Sarac. Cleveland Clinic, Cleveland, Ohio
Objectives: Persistent retrograde false lumen (FL)
perfusion is a common mode of failure after thoracic endo-
vascular aortic repair (TEVAR) for chronic dissection. Ob-
jectives were to describe a novel endovascular approach for
false lumen occlusion and assess outcomes.
Methods: From 2009 to 2013, 20 patients with chronic
thoracoabdominal dissection underwent adjunctive FL
embolization using covered stent devices (Fig) for persistent
retrograde perfusion. Mean age was 636 11 years. Eight pa-
tients had type B dissection, and 12 had prior type A repair
and were deemed high risk for open operation. Three pa-
tients had patent FL after previous TEVAR coverage sparing
the celiac artery and underwent FL embolization as an iso-
lated procedure. In the remaining 17, embolization was per-
formed adjunctively at the time of initial TEVAR or
extension (n ¼ 15) and elephant trunk completion (n ¼
2). Covered stent devices included: illiac plugs (n ¼ 17),
nitinol embolization plugs (n ¼ 2), and occluded stent graft
(n ¼ 1). More than one device was used in 14 patients.
Results: There was one hospital death due to left sub-
clavian artery aneurysm rupture but no stroke, paraplegia,myocardial infarction, or renal failure. Mean follow-up
was 25 6 19 months. During surveillance computed to-
mography imaging, FL thrombosis was noted in all patients
(Fig), but three required further embolization because the
thrombosis was incomplete. Mean maximum aortic diam-
eter decreased from 64 6 14 to 59 6 15 mm. There was
one late death from intracranial hemorrhage and no aortic
ruptures.
Conclusions: Adjunctive FL embolization with a
covered stent device promotes thrombosis and remodeling
after stent grafting the true lumen for chronic dissection.
Further study of this strategy is warranted.
Fig. False lumen embolization using covered stent device in
chronic dissection. The ﬁrst image shows the volume rendered
computed tomography image at 2 year follow-up, showing the
stent graft in true lumen and an iliac plug device adjacently in false
lumen. The second image shows complete thrombosis of false
lumen in the area of the iliac plug device and an intact ﬂow
through the true lumen with stent graft.
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Objectives: The outcomes of high-risk patients receiving
elective repair of aortic archpathologieswith customized fenes-
trated or branched stent grafts (FBSG) were evaluated.
Methods: Single-center, prospective, noncomparative
study using customized fenestrated grafts or the Zenith
Arch-branch endograft (Cook Medical). All patients were
denied open surgical therapy.
Results: During a 2-year period, 14 patients (10 men;
age 66 6 8 years) received FBSG involving the aortic arch
(six customized fenestrated, eight Zenith A-branch). Six
patients had previous thoracic aortic repair. The maximal
aortic diameter was 6 6 1 cm, and indication for surgery
included aortic arch aneurysms (n ¼ 5 [36%]), penetrating
arch ulcers (n ¼ 2 [14%]), type B dissection with
